| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF01535938 |
| P8608 | Fatcat ID | release_elztjs6opbexbmml3cm3juneiq |
| P698 | PubMed publication ID | 3058442 |
| P2093 | author name string | R H Davis | |
| J R Mathias | |||
| M H Clench | |||
| P2860 | cites work | Domperidone, a new dopamine antagonist | Q34729470 |
| Analysis of gastric emptying data | Q36649173 | ||
| 99mTc-labeled solid-phase meal: a quantitative clinical measurement of human gastric emptying | Q38579862 | ||
| Gastrointestinal motility disorders | Q39738966 | ||
| Review of the current status of prokinetic agents in gastroenterology | Q39864127 | ||
| Dopamine antagonists in the upper gastrointestinal tract. | Q40185891 | ||
| Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic | Q40248870 | ||
| Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study | Q41105875 | ||
| Relationship between impaired gastric emptying and abnormal gastrointestinal motility. | Q41468992 | ||
| Manometric evaluation of functional upper gut symptoms. | Q51638349 | ||
| Effects of oral domperidone on gastric emptying and motility. A double-blind comparison with placebo and metoclopramide | Q67029233 | ||
| Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus | Q68989565 | ||
| Effect of lidamidine hydrochloride and loperamide on gastric emptying and transit of the small intestine. A double-blind study | Q69988485 | ||
| Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy | Q70044293 | ||
| Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis | Q70044297 | ||
| Development of an improved multi-pressure-sensor probe for recording muscle contraction in human intestine | Q70049691 | ||
| Clinical evaluation of domperidone in the treatment of chronic postprandial idiopathic upper gastrointestinal distress | Q70217232 | ||
| Gastric and Small Intestinal Myoelectric Dysrhythmia Associated with Chronic Intractable Nausea and Vomiting | Q70932859 | ||
| Dyspepsia, antral motor dysfunction, and gastric stasis of solids | Q71127769 | ||
| Gastric emptying in patients with diabetes mellitus | Q71259331 | ||
| P433 | issue | 12 | |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 1505-1511 | |
| P577 | publication date | 1988-12-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study. | |
| P478 | volume | 33 |
| Q54280892 | A novel series of 6-methoxy-1H-benzotriazole-5-carboxamide derivatives with dual antiemetic and gastroprokinetic activities. |
| Q48318685 | A novel series of N-(hexahydro-1,4-diazepin-6-yl) and N-(hexahydroazepin- 3-yl)benzamides with high affinity for 5-HT3 and dopamine D2 receptors |
| Q39385451 | ACG and CAG Clinical Guideline: Management of Dyspepsia |
| Q71993919 | Ampulla of Vater/duodenal wall spasm diagnosed by antroduodenal manometry |
| Q34379401 | Cardiac safety concerns for domperidone, an antiemetic and prokinetic, and galactogogue medicine |
| Q67505906 | Chronic intestinal pseudoobstruction in a patient with heart-lung transplant. Therapeutic effect of leuprolide acetate |
| Q34508541 | Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis |
| Q69194305 | Debilitating "functional" bowel disease controlled by leuprolide acetate, gonadotropin-releasing hormone (GnRH) analog |
| Q34066979 | Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group |
| Q34626516 | Domperidone: review of pharmacology and clinical applications in gastroenterology |
| Q50172701 | Duodenogastric bile reflux and gastrointestinal motility in pathogenesis of functional dyspepsia |
| Q43861622 | Dyspeptic symptoms and gastric emptying of solids in patients with functional dyspepsia. Role of Helicobacter pylori infection |
| Q72497891 | Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study |
| Q47944738 | Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study |
| Q39472572 | Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction |
| Q35628118 | Electrogastrography in non-ulcer dyspepsia |
| Q24185951 | Erythromycin and related macrolides for gastroparesis |
| Q39493613 | Functional dyspepsia. Current treatment recommendations |
| Q89805655 | Gastrointestinal Involvement in Systemic Sclerosis: An Update |
| Q34601078 | H(2) receptor antagonists and prokinetics in dyspepsia: a critical review |
| Q40920542 | Management of non-ulcer dyspepsia |
| Q53017567 | Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia. |
| Q50008959 | Neuromuscular diseases of the gastrointestinal tract |
| Q77904056 | Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents |
| Q73946180 | Patient-based assessment in dyspepsia: development and validation of Dyspepsia Symptom Severity Index (DSSI) |
| Q24234257 | Pharmacological interventions for non-ulcer dyspepsia |
| Q24244245 | Pharmacological interventions for non-ulcer dyspepsia |
| Q24244795 | Pharmacological interventions for non-ulcer dyspepsia |
| Q24188067 | Pharmacological interventions for somatoform disorders in adults |
| Q35176998 | Pharmacotherapy for intestinal motor and sensory disorders |
| Q74129597 | Predictors of response to a behavioral treatment in patients with chronic gastric motility disorders |
| Q57688729 | Prokinetics for functional dyspepsia |
| Q33836928 | Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis. |
| Q47860881 | Relation of endometriosis and neuromuscular disease of the gastrointestinal tract: new insights |
| Q68078854 | Roux-limb motility after total gastrectomy and Roux-en-Y anastomosis in patients with Zollinger-Ellison syndrome |
| Q73039900 | Small bowel manometry |
| Q34368630 | The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis |
Search more.